“The commitment and talent of our advisory board has been instrumental to the ongoing development of our broad portfolio of highly specific therapeutic, vaccine and diagnostic candidates,” said
“Never before has there been a more urgent need for therapy, diagnostic and vaccine candidates that are highly specific for their intended target,” said
ProMIS’
Neil R. Cashman , M.D., is Chief Scientific Officer atProMIS Neurosciences and Professor of Medicine at theUniversity of British Columbia (UBC), where he holds the Canada Research Chair in Neurodegeneration and Protein Misfolding Diseases and serves as the Director of the UBC ALS Centre.Dr. Cashman is recognized as a pioneer in the field of prion-like misfolded proteins and their role in development of neurodegenerative diseases, in particular ALS and AD.Neil Cashman is co-chair of theSAB .Sharon Cohen , M.D., is a trained behavioral neurologist and former speech language pathologist. Her memory clinic and dementia clinical trial program at the Toronto Memory Programme are the largest and most active inCanada and have contributed substantially to patient care and to global clinical trial cohorts. Through her commitment to knowledge translation and her passion for clinically meaningful outcomes,Dr. Cohen provides a valuable perspective which places the patient at the center of Alzheimer’s drug development programs.Hans Frykman M.D ., Ph.D., is the CEO and medical director ofBC Neuroimmunology Lab andNeurocode Labs and clinical assistant professor of medicine atUniversity of British Columbia . With a 35-year history of delivering highly specific clinical neuroimmunology testing to the North American marketplace, BC Neuroimmunology lab is a technology leader and is academically collaborating with several leading centers inEurope and theUSA . Neurocode labs is Canada’s first and only clinical whole exome sequencing facility. It has a particular focus in seizure disorder, cardiac sequencing and sequencing of the neonate.Todd E. Golde , M.D., Ph.D., is Director of theCenter for Translational Research in Neurodegenerative Disease at theUniversity of Florida where he directs a robust program of scientific discovery aimed at translating basic discoveries in neurodegenerative disease into diagnostics and treatments for patients.Dr. Golde is co-chair of theSAB .William C. Mobley , M.D., Ph.D., is Associate Dean for Neurosciences Initiatives, Distinguished Professor of Neurosciences,Florence Riford Chair for Alzheimer Disease at theUniversity of California, San Diego (UCSD), and the university’s Executive Director of the Down SyndromeCenter for Research and Treatment . Dr. Mobley’s research focuses on the neurobiology of neuronal dysfunction in developmental and age-related disorders of the nervous system.C. Warren Olanow , M.D., is the past Henry P. andGeorgette Goldschmidt Professor and Chairman of theDepartment of Neurology at theMount Sinai School of Medicine inNew York City , and present Professor Emeritus in theDepartment of Neurology and in theDepartment of Neuroscience .Andre Strydom , M.D., Ph.D., is a professor in theInstitute of Psychiatry , Psychology and Neuroscience at King’s College London, and Honorary Consultant psychiatrist,South London and theMaudsley NHS Trust . His current projects and collaborations include the LonDownS consortium, funded by theWellcome Trust / MRC, to study the neurobiology of Alzheimer’s Disease in Down syndrome to understand the underlying factors that may influence variation in age of onset of symptoms. His research in Down syndrome includes investigation of biomarkers of cognitive decline including those related to excess amyloid production, oxidative stress, and neurodegeneration. He has been an investigator on clinical trials of new drug treatment options in Down syndrome, fragile X syndrome and autism.Rudolph E. Tanzi , Ph.D., is a neuroscientist and geneticist with scientific expertise in Alzheimer’s disease and brain health. He serves as Vice-Chair of Neurology, Director of the Genetics and Aging Research Unit, and as a Director of the Henry andAllison McCance Center for Brain Health atMassachusetts General Hospital . He is also the Joseph P. andRose F. Kennedy Professor of Neurology atHarvard Medical School .Lary C. Walker , Ph.D., is Associate Professor of Neurology and Research Professor atEmory University Yerkes National Primate Research Center . Dr. Walker’s research has been directed toward understanding the mechanisms by which the Alzheimer-associated proteins amyloid beta and tau form pathogenic assemblies in vivo and how these agents spread in the brain.
About Dr.
About
Visit us at www.promisneurosciences.com, follow us on Twitter and LinkedIn. To learn more about protein misfolding diseases, listen to Episodes 11, 24, of Saving Minds, a podcast available at iTunes or Spotify.
For media inquiries, please contact:
shanti.skiffington@gmail.com
Tel. 617 921-0808
The TSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This information release contains certain forward-looking information. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company’s current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its public securities filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Source:
2020 GlobeNewswire, Inc., source